Skip to main content
Top
Gepubliceerd in: Quality of Life Research 7/2015

01-07-2015

Mapping the disease-specific LupusQoL to the SF-6D

Auteurs: Rachel Meacock, Mark Harrison, Kathleen McElhone, Janice Abbott, Sahena Haque, Ian Bruce, Lee-Suan Teh

Gepubliceerd in: Quality of Life Research | Uitgave 7/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To derive a mapping algorithm to predict SF-6D utility scores from the non-preference-based LupusQoL and test the performance of the developed algorithm on a separate independent validation data set.

Method

LupusQoL and SF-6D data were collected from 320 patients with systemic lupus erythematosus (SLE) attending routine rheumatology outpatient appointments at seven centres in the UK. Ordinary least squares (OLS) regression was used to estimate models of increasing complexity in order to predict individuals’ SF-6D utility scores from their responses to the LupusQoL questionnaire. Model performance was judged on predictive ability through the size and pattern of prediction errors generated. The performance of the selected model was externally validated on an independent data set containing 113 female SLE patients who had again completed both the LupusQoL and SF-36 questionnaires.

Results

Four of the eight LupusQoL domains (physical health, pain, emotional health, and fatigue) were selected as dependent variables in the final model. Overall model fit was good, with R2 0.7219, MAE 0.0557, and RMSE 0.0706 when applied to the estimation data set, and R2 0.7431, MAE 0.0528, and RMSE 0.0663 when applied to the validation sample.

Conclusion

This study provides a method by which health state utility values can be estimated from patient responses to the non-preference-based LupusQoL, generalisable beyond the data set upon which it was estimated. Despite concerns over the use of OLS to develop mapping algorithms, we find this method to be suitable in this case due to the normality of the SF-6D data.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
2.
go back to reference Sullivan, S., Lyles, A., Luce, B., & Grigar, J. (n.d.). AMCP guidance for submission of clinical and economic evaluation data to support formulary listing in U.S. health plans and pharmacy benefits management organizations. Journal of Managed Care Pharmacy, 7(4), 272–282. Sullivan, S., Lyles, A., Luce, B., & Grigar, J. (n.d.). AMCP guidance for submission of clinical and economic evaluation data to support formulary listing in U.S. health plans and pharmacy benefits management organizations. Journal of Managed Care Pharmacy, 7(4), 272–282.
4.
go back to reference Gold, M. R. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press. Gold, M. R. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
5.
go back to reference Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. L. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European Journal of Health Economics, 11(2), 215–225. doi:10.1007/s10198-009-0168-z.PubMedCrossRef Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. L. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European Journal of Health Economics, 11(2), 215–225. doi:10.​1007/​s10198-009-0168-z.PubMedCrossRef
8.
go back to reference McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I. N., Ahmad, Y., Gordon, C., & Teh, L. S. (2007). Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis and Rheumatism, 57(6), 972–979. doi:10.1002/art.22881.PubMedCrossRef McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I. N., Ahmad, Y., Gordon, C., & Teh, L. S. (2007). Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis and Rheumatism, 57(6), 972–979. doi:10.​1002/​art.​22881.PubMedCrossRef
11.
go back to reference Petri, M. (2002). Epidemiology of systemic lupus erythematosus. Best Practice and Research Clinical Rheumatology, 16(5), 847–858.PubMedCrossRef Petri, M. (2002). Epidemiology of systemic lupus erythematosus. Best Practice and Research Clinical Rheumatology, 16(5), 847–858.PubMedCrossRef
12.
go back to reference McElhone, K., Abbott, J., & Teh, L. S. (2006). A review of health related quality of life in systemic lupus erythematosus. Lupus, 15(10), 633–643.PubMedCrossRef McElhone, K., Abbott, J., & Teh, L. S. (2006). A review of health related quality of life in systemic lupus erythematosus. Lupus, 15(10), 633–643.PubMedCrossRef
14.
go back to reference Touma, Z., Gladman, D. D., Ibañez, D., & Urowitz, M. B. (2011). Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? The Journal of Rheumatology, 38(9), 1898–1905. doi:10.3899/jrheum.110007.PubMedCrossRef Touma, Z., Gladman, D. D., Ibañez, D., & Urowitz, M. B. (2011). Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? The Journal of Rheumatology, 38(9), 1898–1905. doi:10.​3899/​jrheum.​110007.PubMedCrossRef
16.
go back to reference Drummond, M. F., Wilson, D. A., Kanavos, P., Ubel, P., & Rovira, J. (2007). Assessing the economic challenges posed by orphan drugs. International Journal of Technology Assessment in Health Care, 23(1), 36–42. doi:10.1017/S0266462307051550.PubMedCrossRef Drummond, M. F., Wilson, D. A., Kanavos, P., Ubel, P., & Rovira, J. (2007). Assessing the economic challenges posed by orphan drugs. International Journal of Technology Assessment in Health Care, 23(1), 36–42. doi:10.​1017/​S026646230705155​0.PubMedCrossRef
17.
go back to reference Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.PubMedCrossRef
18.
go back to reference Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.PubMedCrossRef Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.PubMedCrossRef
21.
go back to reference Ware, J. E., Snow, K. K., Kosinski, M., Gandek, B., & Institute NEMCHH. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center. Ware, J. E., Snow, K. K., Kosinski, M., Gandek, B., & Institute NEMCHH. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center.
22.
go back to reference Ware, J Jr, Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef Ware, J Jr, Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef
23.
go back to reference Sanchez, M., McGwin, G., Duran, S., Fernandez, M., Reveille, J., Vila, L., & Alarcon, G. (2009). Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): Use of the SF-6D. Clinical and Experimental Rheumatology, 27, 64–71. Sanchez, M., McGwin, G., Duran, S., Fernandez, M., Reveille, J., Vila, L., & Alarcon, G. (2009). Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): Use of the SF-6D. Clinical and Experimental Rheumatology, 27, 64–71.
24.
go back to reference Aggarwal, R., Wilke, C. T., Pickard, A. S., Vats, V., Mikolaitis, R., Fogg, L., & Jolly, M. (2009). Psychometric properties of the EuroQol-5D and short form-6D in patients with systemic lupus erythematosus. The Journal of Rheumatology, 36(6), 1209–1216. doi:10.3899/jrheum.081022.PubMedCrossRef Aggarwal, R., Wilke, C. T., Pickard, A. S., Vats, V., Mikolaitis, R., Fogg, L., & Jolly, M. (2009). Psychometric properties of the EuroQol-5D and short form-6D in patients with systemic lupus erythematosus. The Journal of Rheumatology, 36(6), 1209–1216. doi:10.​3899/​jrheum.​081022.PubMedCrossRef
25.
go back to reference Harrison, M. J., Ahmad, Y., Haque, S., Dale, N., Teh, L.-S., Snowden, N., & Bruce, I. N. (2012). Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus. The Journal of Rheumatology, 39(4), 735–742. doi:10.3899/jrheum.110648.PubMedCrossRef Harrison, M. J., Ahmad, Y., Haque, S., Dale, N., Teh, L.-S., Snowden, N., & Bruce, I. N. (2012). Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus. The Journal of Rheumatology, 39(4), 735–742. doi:10.​3899/​jrheum.​110648.PubMedCrossRef
26.
go back to reference Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., & Winchester, R. J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25(11), 1271–1277.PubMedCrossRef Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., & Winchester, R. J. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25(11), 1271–1277.PubMedCrossRef
28.
go back to reference Ahmad, Y., & Bruce, I. (2004). Sunclinical atherosclerosis in systemic lupus erythematosus. The Journal of Rheumatology, 31, 841–843.PubMed Ahmad, Y., & Bruce, I. (2004). Sunclinical atherosclerosis in systemic lupus erythematosus. The Journal of Rheumatology, 31, 841–843.PubMed
29.
30.
31.
go back to reference Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., & Busschbach, J. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727. doi:10.1007/s11136-012-0322-4.PubMedCentralPubMedCrossRef Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., & Busschbach, J. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727. doi:10.​1007/​s11136-012-0322-4.PubMedCentralPubMedCrossRef
32.
go back to reference Brazier, J., Connell, J., Papaioannou, D., Mukuria, C., Mulhern, B., Peasgood, T., Parry, G. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment doi:10.3310/hta18340. Brazier, J., Connell, J., Papaioannou, D., Mukuria, C., Mulhern, B., Peasgood, T., Parry, G. (2014). A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment doi:10.​3310/​hta18340.
34.
35.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences. UK: Psychology Press. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. UK: Psychology Press.
36.
go back to reference Bansback, N., Marra, C., Tsuchiya, A., Anis, A., Guh, D., Hammond, T., & Brazier, J. (2007). Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Care & Research, 57(6), 963–971. doi:10.1002/art.22885.CrossRef Bansback, N., Marra, C., Tsuchiya, A., Anis, A., Guh, D., Hammond, T., & Brazier, J. (2007). Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Care & Research, 57(6), 963–971. doi:10.​1002/​art.​22885.CrossRef
37.
go back to reference Harrison, M. J., Lunt, M., Verstappen, S. M., Watson, K. D., Bansback, N. J., & Symmons, D. P. (2010). Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health and Quality of Life Outcomes, 8(1), 21. doi:10.1186/1477-7525-8-21.PubMedCentralPubMedCrossRef Harrison, M. J., Lunt, M., Verstappen, S. M., Watson, K. D., Bansback, N. J., & Symmons, D. P. (2010). Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health and Quality of Life Outcomes, 8(1), 21. doi:10.​1186/​1477-7525-8-21.PubMedCentralPubMedCrossRef
38.
go back to reference Gabriel, S., Drummond, M., Maetzel, A., Boers, M., Coyle, D., Welch, V., & Tugwell, P. (2003). OMERACT 6 Economics Working Group report: A proposal for a reference case for economic evaluation in rheumatoid arthritis. The Journal of Rheumatology, 30(4), 886–890.PubMed Gabriel, S., Drummond, M., Maetzel, A., Boers, M., Coyle, D., Welch, V., & Tugwell, P. (2003). OMERACT 6 Economics Working Group report: A proposal for a reference case for economic evaluation in rheumatoid arthritis. The Journal of Rheumatology, 30(4), 886–890.PubMed
39.
40.
go back to reference Feeny, D., Spritzer, K., Hays, R. D., Liu, H., Ganiats, T. G., Kaplan, R. M., & Fryback, D. G. (2012). Agreement about identifying patients who change over time: Cautionary results in cataract and heart failure patients. Medical Decision Making, 32(2), 273–286. doi:10.1177/0272989X11418671.PubMedCentralPubMedCrossRef Feeny, D., Spritzer, K., Hays, R. D., Liu, H., Ganiats, T. G., Kaplan, R. M., & Fryback, D. G. (2012). Agreement about identifying patients who change over time: Cautionary results in cataract and heart failure patients. Medical Decision Making, 32(2), 273–286. doi:10.​1177/​0272989X11418671​.PubMedCentralPubMedCrossRef
42.
go back to reference Kirwan, J. R., Boonen, A., Harrison, M. J., Hewlett, S. E., Wells, G. A., Singh, J. A., & Dworkin, R. H. (2011). OMERACT 10 patient perspective virtual Campus: Valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. The Journal of Rheumatology, 38(8), 1728–1734. doi:10.3899/jrheum.110393.PubMedCrossRef Kirwan, J. R., Boonen, A., Harrison, M. J., Hewlett, S. E., Wells, G. A., Singh, J. A., & Dworkin, R. H. (2011). OMERACT 10 patient perspective virtual Campus: Valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health. The Journal of Rheumatology, 38(8), 1728–1734. doi:10.​3899/​jrheum.​110393.PubMedCrossRef
45.
46.
go back to reference McELHONE, K., Castelino, M., Abbott, J., Bruce, I. N., Ahmad, Y., Shelmerdine, J., & Teh, L. S. (2010). The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. The Journal of Rheumatology, 37(11), 2273–2279. doi:10.3899/jrheum.091277.PubMedCrossRef McELHONE, K., Castelino, M., Abbott, J., Bruce, I. N., Ahmad, Y., Shelmerdine, J., & Teh, L. S. (2010). The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. The Journal of Rheumatology, 37(11), 2273–2279. doi:10.​3899/​jrheum.​091277.PubMedCrossRef
Metagegevens
Titel
Mapping the disease-specific LupusQoL to the SF-6D
Auteurs
Rachel Meacock
Mark Harrison
Kathleen McElhone
Janice Abbott
Sahena Haque
Ian Bruce
Lee-Suan Teh
Publicatiedatum
01-07-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2015
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-014-0892-4

Andere artikelen Uitgave 7/2015

Quality of Life Research 7/2015 Naar de uitgave